ArticlePatient preference and adherence2023

Barrier Factors of Adherence to Dupilumab Self-Injection for Severe Allergic Disease: A Non-Interventional Open-Label Study.

Kei Hosoya et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.